| Name | Title | Contact Details |
|---|
Pharos Innovations is a Northfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community Health Resources` (CHR) mission is to help adults, children and families find Real Hope for the challenges of Real Life through an array of community based mental health, substance use, child welfare, supported housing, foster care, prevention and wellness services and integrated care. Our name embodies our commitment to community based care, utilizing all available resources to achieve change, and instill hope for a healthy, happy and productive future. CHR is proud to provide services that achieve Real Quality with Real Results. CHR’s history dates back to the 1960s, and since its creation, has become a trusted community resource and well-respected service provider. We employ over 700 experienced staff members who provided services to more than 18,000 individuals in the past year. We offer effective, accesible and affordable behavioral healthcare through 80 programs and 32 locations. As we anticipate changing needs, we will offer new programs, recruit exceptional staff, collaborate with other providers, and explore new funding sources. The driving force of our growth continues to be meeting the needs of those we serve.
The new Actavis, Inc. (NYSE:ACT) is a combination of the previously separate Watson Pharmaceuticals, Inc. and Swiss-based Actavis Group. Actavis, Inc. is a specialty pharmaceutical company that develops, manufactures and distributes generic, brand and biosimilar products. The Company has global headquarters in Parsippany, NJ and international headquarters in Zug, Switzerland.
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.
BioInformatics is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.